Synopsis of recent research by authors named "Jeffrey Wefel"
- Jeffrey Wefel's recent research centers around neurocognitive implications in cancer treatments, particularly focusing on cognitive dysfunction in patients affected by castration-resistant prostate cancer and other malignancies.
- Key findings highlight the need for functional assessments, such as the Timed Up and Go (TUG) and Short Physical Performance Battery (SPPB), to evaluate physical and cognitive performance in cancer patients, emphasizing the link between treatment and cognitive impairment.
- Wefel also advocates for an improved understanding of cancer-related cognitive impairment (CRCI) through clinical research initiatives aimed at developing interventions to enhance cognitive outcomes and quality of life for cancer survivors.
